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Available online 9 December 2012Abstract Elevated plasma free fatty acid (FFA) level is common in many pathological conditions, including neurological
disorders, and their deleterious effects on various cells have been well documented. However, it remains to be investigated
whether elevated FFAs would have a direct effect on neural stem cells (NSCs). Here, we reported that palmitic acid (PA) impaired
cell viability and increased apoptosis of NSCs significantly in a dose- and time-dependent manner. Increased protein levels of Bax
and cleaved caspase 3 coupled with decreased expression of Bcl-2 were also observed in NSCs with increasing dose or time of PA
treatment, whereas caspase 3 expression remained relatively unaltered. In parallel to this, the expression of phospho-c-Jun
N-terminal kinase (p-JNK) in NSCs challenged with PA was increased significantly; however, JNK expression appeared stable.
Remarkably, JNK inhibitor effectively reduced the apoptosis of NSCs induced by PA. The expression of phospho-p38 (p-p38), p38,Abbreviations: BSA, bovine serum albumin; DAPI, 4′, 6-diamidino- 2-phenylindole; E13.5, embryonic day 13.5; ERK1/2, extracellular
regulated protein kinase 1/2; FFAs, free fatty acids; GFAP, glial fibrillary acidic protein; JNK, c-Jun N-terminal kinase; MAP2,
microtubule-associated protein 2; MAPKs, mitogen-activated protein kinases; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide; NSCs, neural stem cells; PA, palmitic acid; p-ERK1/2, phospho-extracellular regulated protein kinase 1/2; p-JNK, phospho-c-Jun
N-terminal kinase; p-p38, phospho-p38; SA, stearic acid; TUNEL, terminal deoxynucleotidyttransferase-mediated dUTP nick ending labeling.
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258 Q. Yuan et al.phospho-extracellular regulated protein kinases 1/2 (p-EKR1/2) and EKR1/2 in NSCs was not affected by PA treatment. In
consideration of the above, it is suggested that elevated plasma FFA level may induce apoptosis of NSCs in vivo, and that this might
be one of possible underlying mechanisms for the cognitive disturbance in neurological disorders.
© 2012 Elsevier B.V. All rights reserved.Introduction
Free fatty acids (FFAs), including saturated and unsaturated
FFAs, are the major source of lipid energy in human body and
released mainly from adipose tissue by lipolysis of triglycer-
ides (Miles and Nelson, 2007). FFAs circulating in the plasma
are largely bound to the albumin, with a concentration of ~0.1
to 1.0 mM. Lipotoxicity follows when non-adipose cells are
exposed to chronic elevation of FFAs, which can result from
disturbed balance between release and clearance of FFAs,
e.g., on a high fat diet or under other metabolic conditions
(Mittendorfer, 2011; Boden, 2008). Besides fatty acids traf-
ficking alterations, high level of FFAs may also be a conse-
quence of membrane phospholipid degradation caused by
activated phospholipases in many pathological conditions, such
as trauma, hypoxia and stroke (Farooqui and Horrocks, 1998). It
has been reported that FFAs accumulated acutely after
traumatic brain injury, with the concentration of palmitic
acid (PA) in the brain increasing from ~60 to 180 μMand stearic
acid (SA) from ~50 to 350 μM (Lipton, 1999). Moreover,
elevated plasma FFA level can inhibit insulin's anti-lipolytic
action which further increases the release of FFAs into
circulation (Boden, 2008).
Pathological accumulation of saturated FFAs in the human
body can pose serious threat to normal cellular homeostasis,
which has been suggested to be involved in the development
of many chronic diseases, such as obese, diabetes and cardio-
vascular diseases (Gomez-Lechon et al., 2007; Saunders et
al., 2008). Importantly, brain could uptake FFAs from plasma
through the blood–brain barrier (Wang et al., 1994). In other
words, elevated FFA level can exacerbate cellular damage
directly on brain, leading to different extent of cognitive
decline and brain abnormalities (Adibhatla and Hatcher, 2008).
In addition, excessive saturated FFAs could freely penetrate
placental barrier, thereby interfering with the development
and growth of embryos, including the development of brain
(Yu et al., 2009; Elahi et al., 2009; Tozuka et al., 2009). These
data suggest that FFAs can readily enter and exert their
destructive effects on the brain.
There is growing evidence indicating that the deleterious
effects of saturated FFAs on the brain have been associated
with alterations of its cells. Cell death was obviouswhen nerve
growth factor-differentiated PC12 cells were exposed to FFAs,
such as SA and PA (Ulloth et al., 2003; Almaguel et al., 2009).
FFAs exerted Alzheimer-like pathological effects on neurons
through their actions on primary rat cortical astroglia (Patil et
al., 2007). Neural stem cells (NSCs), residing in both fetal and
adult brain, have been suggested to differentiate into various
kinds of neurons and astrocytes and play important roles in the
development and injuries repair of the brain (Temple, 2001;
Alvarez-Buylla et al., 2002; Kim, 2004). Many factors have
been shown to exert their effects on NSCs, influencing their
proliferation, apoptosis and differentiation (Gao and Gao,
2007; Anthony et al., 2008). However, there is an apparentlack of information about the effects of saturated FFAs on
NSCs. In view of this, it is desirable to explore the effects of
elevated saturated FFAs on NSCs, as this might offer a possible
explanation for the cognitive alterations and brain abnormal-
ities of neurological disorders due to elevation of FFAs. In the
present study, we have employed suspension culture to obtain
mouse NSCs in vitro in the form of neurospheres. We next
investigated the impact of PA, the most abundant saturated
fatty acid in the diet or in the plasma, on NSCs in vitro with
an aim to gain a further understanding of the underlying
molecular mechanism of its effects on the stem cells.
Materials and methods
All experiments were carried out in accordance with “the
National Institute of Health Guide for the Care and Use of
Laboratory Animals revised 1996”, which is also adopted by
the Laboratory Animal Center, ShandongUniversity. All efforts
were made to minimize the pain and suffering of mice during
all the procedures.
Primary culture of embryonic NSCs
Embryos of Kung Ming mouse (purchased from Laboratory
Animal Center, Shandong University) at E13.5 were collected
by Cesarean section of pregnant mice, and then the
telencephalons of the embryos were isolated and mechani-
cally disrupted into single cells by repeated pipetting in a
serum free DMEM/F12 (1:1) medium (Invitrogen, Carlsbad, CA,
USA) for three times. After being filtered, cell number was
counted and cells were seeded at 5×105cells/ml in DMEM/F12
(1:1) medium supplemented with 2% B27 (Gibco, Gaithers-
burg, MD, USA), 20 ng/ml basic fibroblast growth factor (R&D,
Minneapolis, MN, USA), 100 U/ml penicillin (Sigma-Aldrich, St.
Louis, MO, USA) and 100 μg/ml streptomycin (Sigma-Aldrich)
in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. After
5 days of culture, neuropheres were harvested by centrifuga-
tion, dissociated using trypsin and EDTA (Sigma-Aldrich), and
re-seeded for following experiments.
Characterization of NSCs
For examination of NSC specific marker, neurospheres were
seeded on coverslips and cultured for 24 h before fixation.
For proliferation of NSCs, dissociated NSCs were seeded
on coverslips and cultured for 3 days and supplemented with
BrdU 4 h before fixed. To examine the differentiation of
NSCs, dissociated NSCs were seeded on coverslips, added
with differentiation medium (containing 2% fetal bovine
serum without growth factors) and cultured for 5 days. After
fixation, cells on coverslips were incubated with mouse
anti-Nestin monoclonal antibody (1:500; Millipore, Billerica,
MA, USA), mouse anti-BrdU monoclonal antibody (1:1000;
259Sigma-Aldrich), mouse anti-microtubule-associated protein
2 (MAP2) monoclonal antibody (1:200; Millipore) or mouse
anti-glial fibrillary acidic protein (GFAP) monoclonal antibody
(1:500; Millipore). FITC- or TRITC-conjugated goat anti-mouse
IgG (1:200; Millipore) was used as secondary antibodies. Cell
nuclei were counterstainedwith 4′, 6-diamidino-2-phenylindole
(DAPI, 5 μg/ml; Vector Laboratories, Burlingame, CA, USA) and
photoimages were captured using a fluorescence microscope
(Olympus, Tokyo, Japan).
Preparation of PA-albumin complexes
PA (Sigma-Aldrich) was first dissolved in 100% ethanol at 70 °C.
Then PA was mixed with fatty acid-free and low endotoxin
bovine serum albumin (BSA, Sigma-Aldrich) at 50 °C for a final
PA concentration of 25–200 mM as described before (Lee et al.,
2001). The stock solutions were sterilized by filtering and stored
at −20 °C. The control group receiving ethanol and BSAwithout
PA was similarly prepared. Fresh working solutions were pre-
pared each time by diluting different concentrations of stock
solutions in DMEM/F12 (1:1) medium, with all the final PA
solutions containing the same amount of BSA.
Cell viability assay
Cell viability of NSCs was assessed by employing the 3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) (Sartorius, Goettingen, Germany) assay. Briefly, dissoci-
ated NSCs were seeded onto 96-well culture plate at a density
of 5000 cells per well and cultured in a humidified atmosphere
of 5% CO2 and 95% air at 37 °C. After culturing for 24 h, the
medium was aspirated out, and cells were treated with various
concentrations of PA (0, 50, 100, 200, 400 and 800 μM) for 24 h
or 48 h. Four hours before the end of 24 h or 48 h incubation,
5 mg/mlMTTwith a volume of 20 μl was added to eachwell and
further incubation was continued until 24 h or 48 h. Then
the medium was carefully removed, and each well was added
with 200 μl DMSO to lyse the formazan crystals. The absorbance
value of each sample was immediately determined with a
multi-well spectrophotometer (Bio-Rad Laboratories, Shanghai,
PR China) at 490 nm. Three independent experiments were
conducted.
Morphological observations
Passaged NSCs were seeded into culture flask at a density of
5×105cells/ml and cultured for 2–4 days to form neuropheres.
The neurospheres were then seeded on coverslips in 12-well
culture plate and treated with various concentrations of PA
(0, 50, 100, 200, 400 and 800 μM) for 48 h. Images were
captured with a light microscope (Olympus).
TUNEL assay
Dissociated NSCs were seeded on coverslips in 12-well culture
plate. After cultured for 2–4 days, each well was added with
different concentrations of PA (0, 50, 100, 200 and 400 μM) for
48 h or with 400 μM PA for different time durations (12, 24, 36
and 48 h). In situ cell apoptosis caused by PA was determined
using terminal deoxynucleotidyttransferase-mediated dUTPnick ending labeling (TUNEL) staining (Roche Applied Science,
Mannheim, Germany). Briefly, after fixation and perme-
abilization, cells on coverslips were incubated with TUNEL
reaction mixture including terminal deoxynucleotidyl trans-
ferase and fluorescein-labeled nucleotides in a humidified
atmosphere for 1 h at 37 °C in the dark and were then
counterstained with DAPI. Analysis by fluorescence micro-
scope was carried out. Three independent experiments were
conducted.Western blot analysis
Passaged NSCs were seeded into culture flask at a density of
5×105cells/ml and cultured for 2–4 days, and then added
with different concentrations of PA (0, 50, 100, 200 and
400 μM) for 48 h or with 400 μM PA for different times (12, 24,
36 and 48 h). After that, cells were collected, washed with
cold PBS and lysed in cold 1× lysis buffer supplemented with
protease inhibitors. The lysates were centrifuged and super-
natants were collected. Protein concentrations in the super-
natants were then measured using a BCA protein assay kit
(Pierce Biotechnology, Rockford, IL, USA). Equal amounts of
protein (20 μg for each sample) were separated on SDS-PAGE
and electrotransferred onto a polyvinylidene fluoride mem-
brane (0.45 μm, Millipore). After being rinsed in TBST
solution and blocking in 5% nonfat milk, the membranes
were subsequently probed with Bax (1:1000; Santa Cruz
Biotechnology, Inc., CA, USA), Bcl-2 (1:1000; Santa Cruz
Biotechnology, Inc.), cleaved caspase-3 (1:1000; Cell Signaling
Technology, Boston, MA, USA), caspase 3 (1:1000; Cell
Signaling Technology), phospho-p38 mitogen-activated pro-
tein kinase (p-p38 MAPK) (1:1000; Cell Signaling Technology),
p38 MAPK (1:1000; Cell Signaling Technology), phospho-c-Jun
N-terminal kinase (p-JNK) (1:1000; Cell Signaling Technology),
c-Jun N-terminal kinase (JNK) (1:1000; Cell Signaling Tech-
nology), phospho-extracellular regulated protein kinase 1/2
(p-ERK1/2) (1:1000; Cell Signaling Technology), extracellular
regulated protein kinase 1/2 (ERK1/2) (1:1000; Cell Signaling
Technology) and β-actin (1:1000; Sigma-Aldrich) antibodies
and were finally visualized by the enhanced chemilumines-
cence system (Millipore). After developing and fixing, the
intensity of bands on the films was quantified and analyzed
by the Image J software. Three independent experiments
were carried out.JNK inhibitor administration
NSCs cultured for 2–4 days on coverslips or in culture flask
were challenged with 50 μM JNK inhibitor SP600125 (Sigma-
Aldrich) for 1 h, followed by 400 μM PA treatment for 48 h.
The apoptosis of NSCs was then determined by TUNEL assay or
western blot analysis.Statistical analysis
All quantitative data were input into SPSS 11.5 software,
expressed as mean±SD and analyzed by Student's t test.
Differences were considered as significant at Pb0.05.
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Effects of PA on cell viability of NSCs were dose- and
time-dependent
NSCs were isolated from telencephalons of mouse embryos
at embryonic day 13.5 (E13.5) and grown in the form of
neurospheres. As shown in Fig. S1, almost all cells in the
neurospheres were Nestin-positive, and the dissociated NSCs
could incorporate BrdU and differentiate into MAP2-positive
neurons and GFAP-positive astrocytes. All these results con-
firmed the identity of the NSCs. Following the characteriza-
tion of the NSCs, we employed the MTT assay to evaluate the
effect of different doses of PA on cell viability. As shown in
Fig. 1A, PA evidently impaired the cell viability of NSCs in a
dose-dependent manner at 24 h and 48 h, especially at the
concentration of 200 μM, 400 μM and 800 μM (91.14±8.50%,
50.30±6.46% and 29.71±5.37% of control group for 24 h, and
80.50±7.18%, 39.10±5.86% and 17.63±2.45% of control group
for 48 h). In addition, we also examined the cell viability
difference of PA treatment (400 μM) between 24 h and 48 h.
Compared with the results at 24 h, cell viability of NSCs at
48 hwas decreased significantly from the dose of PA at 200 μM
to 800 μM (Fig. 1A).
We next examined the morphological alterations of NSCs
treated with different doses of PA at 48 h under the lightFigure 1 Reduction of cell viability by PA in NSCs. (A) NSCswere
treated with 0, 50, 100, 200, 400 and 800 μM PA for 24 h and 48 h,
respectively, and then cell viability was determined by MTT assay.
Data were expressed as percentages of the control values. Three
independent experiments were carried out. *Pb0.01 vs. the
respective controls; #Pb0.05, ##Pb0.01 vs. the same concentra-
tions of PA treatment at 24 h. (B) Morphological changes of NSCs
by PA (0, 50, 100, 200, 400 and 800 μM) treatment for 48 h. Scale
bars, 500 μm.microscope. Noticeable changes were observed among these
groups (Fig. 1B). Neurospheres in the control and 50 μM PA
groups appeared to grow well. The peri-neurosphere region
was surrounded by a large number of cells.When neurospheres
were treated with 100 μM or 200 μM PA, the cells around
neurospheres were markedly reduced. At 400 μM PA, the
containing cells in the neurospheres were drastically reduced,
in which only occasional cells were detected. At 800 μM PA,
the cells inside the neurospheres were hardly detected.
PA induced apoptosis of NSCs
Due to the decreased cell viability and evident morphological
alterations with PA supplementation, we next sought to deter-
mine the incidence of apoptosis of NSCs challenged with PA.
Results showed that more TUNEL-positive cells occurred in
clusters at a higher dose of PA at 48 h, especially at the
concentrations of 200 μM and 400 μM PA (Fig. 2). In addition,
prolonged PA treatment resulted in a higher percentage of
apoptotic cells (Fig. 3).
Along with the above, we examined the expression of some
classical proteins associated with cell apoptosis in NSCs with
PA treatment, including Bax, Bcl-2, cleaved caspase 3 and
caspase 3. Western blot assay showed that the protein level of
Bax was significantly elevated, while the expression of Bcl-2
was markedly decreased, as the concentration or treatment
time of PA on NSCs was increased (Fig. 4A). The ratio of Bax
and Bcl-2 protein was elevated significantly as the dose of
PA was increased (Fig. 4B) or the duration of PA treatment
extended (Fig. 4C). Moreover, when NSCs were treated with
a higher dose of PA, the protein level of cleaved caspase 3 was
concomitantly elevated. On the other hand, there was no
obvious difference in caspase 3 expression among all groups
(Fig. 4A). Besides being dose-dependent, cleaved caspase-3
expression in NSCs following PA treatment showed a steady
increase in a time-dependent manner; however, expression
of caspase 3 remained relatively unchanged (Fig. 4A). It is
noteworthy that the ratio of cleaved caspase 3 and caspase 3
proteins followed a similar expression trend at a higher dose or
longer duration of PA treatment (Figs. 4D and E).
MAPK pathwaywas involved in the increased apoptosis
of NSCs induced by PA
To further investigate the mechanisms of PA on apoptosis of
NSCs, we next examined the expression of MAPKs, which have
been well documented to be involved in the regulation of cell
proliferation, apoptosis and differentiation. It was found that
with the increase in concentration of PA treatment in NSCs, the
protein level of p-JNK was elevated significantly; however,
the expression of JNK was relatively stable at different PA
doses (Figs. 5A and B). Likewise, the expression of p-p38, p38,
p-ERK1/2 and ERK1/2 in NSCs with different doses of PA
treatment remained relatively unaltered (Figs. 5A, C and D).
We also examined the expression of p-JNK, p-p38 and p-EKR1/2
in NSCs with PA treatment for different time periods. In
prolonged PA treatment, the protein level of p-JNK was
substantially increased, but JNK expression remained rela-
tively constant (Figs. 6A and B). In addition, there were no
obvious changes in the expression of p-p38, p38, p-ERK1/2 and
ERK1/2 in NSCs with different time duration of PA treatment
(Figs. 6A, C and D). These results suggest that increased
Figure 2 Increased apoptosis of NSCs by different doses of
PA treatment. (A) NSCswere treatedwith different doses of PA (0,
50, 100, 200 and 400 μM) at 48 h, determined by TUNEL assay
(green) and counterstained with DAPI (blue). Arrows indicate
TUNEL-positive cells. Scale bars, 50 μm. (B) Bars represent
percentage of TUNEL-positive cells in NSCs induced by PA
treatment. Apoptotic and DAPI-positive cells of 5 fields were
counted and averaged. Data were expressed as mean±SD of three
different experiments. **Pb0.01 vs. control.
Figure 3 Increased apoptosis of NSCs by PA treatment for
different duration. (A) NSCs were treated with 400 μM PA for
different duration (0, 12, 24, 36 and 48 h), determined by TUNEL
assay (green) and counterstained with DAPI (blue). Arrows indicate
TUNEL-positive cells. Scale bars, 50 μm. (B) Bars represent
percentage of TUNEL-positive cells in NSCs treated by PA.
Apoptotic and DAPI-positive cells of 5 fields were counted and
averaged. Data were expressed as mean±SD of three different
experiments. ** Pb0.01 vs. control.
261apoptosis of NSCs by PA might be mediated primarily by JNK
activation.
Increased apoptosis of NSCs induced by PA was JNK
dependent
In order to verify whether p-JNK signaling was responsible
for regulating apoptosis of NSCs induced by PA, SP600125,
a selective JNK inhibitor, was applied to NSCs cultures 1 h
before PA treatment. As shown in Figs. 7A and B, SP600125
significantly attenuated PA-induced apoptosis in NSCs. Con-
currently, the expression of Bax, Bcl-2, cleaved caspase-3
and caspase 3 was also affected greatly with the application of
JNK inhibitor in NSCs before challenged with PA (Figs. 7C–E),
i.e., the protein levels of Bax and cleaved caspase 3 were
obviously elevated, while that of Bcl-2 was greatly reduced.
There was no obvious alteration in caspase 3 expression.Compared with the PA group, the ratio of Bax and Bcl-2 or
cleaved caspase 3 and caspase 3 was clearly decreased after
administration of JNK inhibitor.Discussion
Here, we reported that exposure of NSCs to PA promoted
apoptosis, upregulated the protein levels of Bax and cleaved
caspase 3 and reduced the expression of Bcl-2 in a dose- and
time-dependentway. Furthermore,we found that JNK signaling
was involved in mediating PA-induced apoptosis of NSCs.
Elevated FFA level has been associated with the develop-
ment of many pathological conditions including neurological
disorders. For instance, elevation of FFAs has been suggested
to be a risk factor of Alzheimer's disease, with neurons and
astrocytes being affected, which might be responsible for the
cognitive decline in the brain (Patil et al., 2006, 2008).
Cognitive abilities, such as learning and memory, depend on
Figure 4 Changes of apoptotic-associated protein levels by PA treatment. (A) Protein levels of Bax, Bcl-2, cleaved caspase 3 and
caspase 3 were determined by western blot in NSCs challenged with different doses of PA treatment (0, 50, 100, 200 and 400 μM) at 48 h
or 400 μM PA for different time periods (0, 12, 24, 36 and 48 h). (B and C) Bars represent ratio of Bax and Bcl-2 protein levels in NSCs by
different doses and time of PA treatment. (D and E) Bars represent ratio of cleaved caspase-3 and caspase-3 protein levels in NSCs by
different doses or time of PA treatment. Datawere expressed asmean±SD of three different experiments. *Pb0.05, **Pb0.01 vs. control.
262 Q. Yuan et al.neurogenesis in the brain, which is involved in the proliferation,
apoptosis and differentiation of NSCs and can be influenced by
many stimuli (Fike, 2011; Tesone-Coelho et al., 2012; Lindqvist
et al., 2006; Gao and Gao, 2007). Plasma saturated FFAs, such
as SA and PA, could bring about deleterious effects onmany cell
types, with apoptosis being the most common phenomenon
(Jiang et al., 2010; Wang et al., 2010; Malhi et al., 2006;
Welters et al., 2006; Almaguel et al., 2009; Ricchi et al., 2009).
Therefore, it is worthy to explore whether elevated saturated
FFA level would also influence the apoptosis of NSCs. In the
present study,we have chosen PA as a representative saturated
fatty acid, to explore its effects on NSCs.
As expected, PA could decrease the viability of NSCs in a
dose- and time-dependent manner. In addition to its adverse
effects on cell morphology, our speculation that PA might also
be involved in apoptosis of NSCs was confirmed by TUNEL
assay. Very interestingly, the effects of PA on apoptosis of
NSCs were dose- and time-dependent, indicating that the
severity of neurological disorders might be associated with
different extent of PA elevation. Bcl-2, an anti-apoptotic
protein of Bcl-2 family, was identified in blocking apoptosisrather than promoting proliferation (Korsmeyer et al., 1993).
It is expressed restrictedly in progenitor cells, long-lived cells
and extensively in the developing embryo (Korsmeyer et al.,
1993). Bax can heterodimerize in vivo with Bcl-2 and
accelerate cell apoptosis (Korsmeyer et al., 1993). Moreover,
the ratio of Bax and Bcl-2 appears to determine the survival or
cell death following an apoptotic stimulus (Korsmeyer et al.,
1993), i.e., a high ratio of Bax and Bcl-2 indicates apoptosis.
We show here that the expression of Bax was increased and
that of Bcl-2 decreased in the NSCs following PA treatment.
The increase in the ratio of Bax and Bcl-2 further verified the
apoptosis of NSCs caused by PA. Moreover, the Bcl-2 family,
acts as a checkpoint upstream of caspases (Burlacu, 2003),
which are the key executioners of apoptosis and exert their
actions by the way of cleavage. Caspase 3 is one of the
caspases and the cleavage of caspase 3 leads to the formation
of cleaved caspase 3 whose elevation has been suggested
to promote cell apoptosis (Porter and Janicke, 1999). The
parallel increase in the expression of cleaved caspase 3 and
Bax/Bcl-2 in the present study suggests that the alterations of
cleaved caspase 3 may be mediated by the Bax and Bcl-2
Figure 5 Activation of MAPK pathway in the increased apoptosis of NSCs by different doses of PA treatment. (A) Protein levels of p-JNK,
p-p38 and p-ERK1/2 in NSCs challengedwith different doses of PA (0, 50, 100, 200 and 400 μM) for 48 h were determined by western blot.
(B–D) Quantification of MAPK proteins (p-p38/p38, p-JNK/JNK and (p-ERK1/2)/(ERK1/2)) in NSCs induced by different doses of PA. Data
were expressed as mean±SD of three different experiments. **Pb0.01 vs. control.
Figure 6 Activation of MAPK pathway in the increased apoptosis of NSCs by PA treatment for different duration. (A) Protein levels of
p-JNK, p-p38 and p-ERK1/2 in NSCs were determined by western blot treated with 400 μM PA for different time (0, 12, 24, 36 and 48 h).
(B–D) Quantification of MAPK proteins (p-p38/p38, p-JNK/JNK and (p-ERK1/2)/(ERK1/2)) in NSCs induced by PA treatment for different
duration. Data were expressed as mean±SD of three different experiments. ** Pb0.01 vs. control.
263
Figure 7 Role of JNK signaling in the increased apoptosis and apoptotic-associated protein expression of NSCs by PA. (A) NSCs were
pre-incubated with 50 μM JNK inhibitor SP600125 1 h before PA treatment at 400 μM for 48 h, and determined by TUNEL assay (green)
and counterstained with DAPI (blue). Arrows indicate TUNEL-positive cells. Scale bars, 50 μm. (B) Bars represent percentage of
TUNEL-positive cells. Apoptotic and DAPI-positive cells of 5 fields were counted and averaged. Data were expressed as mean±SD of
three different experiments. **Pb0.01 vs. C, # Pb0.01 vs. PA. (C) NSCs were treated as stated before and protein expression was
determined by western blot. (D and E) Bars represent ratio of Bcl-2 and Bax, or cleaved caspase-3 and caspase-3 protein levels in NSCs
by PA treatment. Data were expressed as mean±SD of three different experiments. **Pb0.01 vs. C, #Pb0.01 vs. PA. C, control; PA,
400 μM palmitic acid; PA+SP, 400 μM palmitic acid+SP600125.
264 Q. Yuan et al.expression. This would further support our view of the effects
of PA on apoptosis of NSCs. In short, alterations of cell
apoptosis and associated proteins in NSCs by PA treatment
suggest that PA switches on the irreversible process of
apoptosis and ultimately leads to apoptosis of NSCs.
The MAPKs, consist of p38s, JNKs and ERKs, are a family of
protein kinases and exert their actions in form of phosphory-
lation. JNK signaling is widely involved in cell apoptosis caused
by various stimuli (Davis, 2000). Besides, JNK is required for
embryonic morphogenesis (Davis, 2000) and can be activated
by raised plasma FFA level, many of which were related to PA
(Jiang et al., 2010; Boden et al., 2005; Hotamisligil, 2005;
Almaguel et al., 2009; Kourtidis et al., 2009). In the present
study, it was found that p-JNK expression was significantly
increased in NSCs on treatment with PA at different doses or
duration. To further confirm the involvement of JNK pathway
in the apoptosis of NSCs by PA, JNK specific inhibitor SP600125
was used to inhibit the JNK activity before PA treatment. It
was found that apoptosis and apoptotic-associated proteins of
NSCs induced by PA treatment were partially attenuated.
These results suggest that PA-induced apoptosis of NSCs
is JNK-dependent, and that JNK might be a potential drug
target for improving brain abnormalities caused by elevated
FFA level.
It is noteworthy that the expression levels of p-p38 and
p-ERK1/2 remained relatively unchanged in spite of theincreasing dose or time of PA treatment. p-38 kinases are
well-recognized in apoptosis, development, differentiation
and cell cycle regulation caused by stress stimuli and cytokines
(Coulthard et al., 2009), while ERK1/2 transfer extracellular
signals into cellular nucleus by receptor-mediated way and
mainly function in cell growth, proliferation and differentia-
tion (Kim and Choi, 2010). Therefore, our data suggest that
p38 and ERK1/2 pathways may not participate in the apoptosis
of NSCs induced by PA. Interestingly, p38 kinases have been
suggested in the apoptosis of PA in many other cell types
(Jiang et al., 2010; Chai and Liu, 2007). The differential
expression of p38 as demonstrated in our study suggests that
p38 activation may depend on a variety of factors, such as cell
type, cell status and the external stimuli.
In this study, we have employed mouse NSCs rather than
human NSCs to explore the effects of PA. In view of this,
further study would be desirable to ascertain if comparable
effects of PA occur in human NSCs. In addition, elevated FFA
level is intimately associated with oxidative stress and high
level of ROS. Therefore, the roles of oxidative stress in the
activation and regulation of JNK and its specific effect on
downstream associated transcription factors are worth pursu-
ing in PA-induced apoptosis of NSCs. It is also desirable to
extend the study in vivo such as to feed the mice with high
fat diet for further exploration of the possible association
between elevation of FFAs and brain disorders.
265In summary, this study has demonstrated that PA can
induce apoptosis of NSCs that is mediated via JNK signaling. It
is speculated that this might be one of possible mechanisms
contributing to the increased incidence of neurological
disorders caused by elevation of FFAs. In light of this, lowering
plasma FFA level to normal level, through adjustment of diets
and/or application of some potential drugs, may be beneficial
to avoid unnecessary neuropsychopathic symptoms and brain
abnormalities.
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